Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMYT

Amryt Pharma (AMYT) Stock Price, News & Analysis

Amryt Pharma logo

About Amryt Pharma Stock (NASDAQ:AMYT)

Advanced Chart

Key Stats

Today's Range
$14.63
$14.76
50-Day Range
$14.55
$14.70
52-Week Range
$6.41
$14.77
Volume
2.39 million shs
Average Volume
757,360 shs
Market Capitalization
$940.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amryt Pharma and its competitors with MarketBeat's FREE daily newsletter.

AMYT Stock News Headlines

Alembic Pharmaceuticals Ltd.
AMYT Historical Data
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
Amryt Pharma Stock (NASDAQ:AMYT), Dividends
See More Headlines

AMYT Stock Analysis - Frequently Asked Questions

Amryt Pharma plc (NASDAQ:AMYT) released its quarterly earnings data on Thursday, November, 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.73) by $0.66. The firm earned $49.33 million during the quarter. Amryt Pharma had a negative net margin of 8.19% and a positive trailing twelve-month return on equity of 1.70%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amryt Pharma investors own include Alibaba Group (BABA), Dynavax Technologies (DVAX), Advanced Micro Devices (AMD), Teladoc Health (TDOC), NIO (NIO), Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2020
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AMYT
CIK
1783010
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1 million
Net Margins
-8.19%
Pretax Margin
-0.56%
Return on Equity
1.70%
Return on Assets
0.75%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.57
Quick Ratio
0.94

Sales & Book Value

Annual Sales
$222.54 million
Price / Sales
4.22
Cash Flow
$0.98 per share
Price / Cash Flow
14.98
Book Value
$5.58 per share
Price / Book
2.63

Miscellaneous

Outstanding Shares
63,960,000
Free Float
60,343,000
Market Cap
$940.21 million
Optionable
Not Optionable
Beta
0.84
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:AMYT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners